Release Date: 13/10/17 09:33 Summary: Ensurance to Increase Fully Underwritten Placement to $3.5m Price Sensitive: Yes Download Document 402.34KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status